Melissa P. Wasserstein, MD, Chief of Pediatric Genetic Medicine at the Children’s Hospital at Montefiore, New York City discusses three rare diseases that she sees at her clinic: Neimann Pick Disease, Krabbe Disease, and Chromosome 22q11.2 deletion syndrome (often referred to as 22Q).

Dr. Wasserstein is an NIH-funded clinical researcher whose work focuses on evaluating the safety and effectiveness of novel treatments for patients with inborn errors of metabolism. Prior to joining CHAM, Dr. Wasserstein was Director of the Program for Inherited Metabolic Diseases at Mount Sinai Health System.